The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation

Clinical trial NCT01423188 · COMPLETED

Trial details

NCT number: NCT01423188
Sponsor: Resverlogix Corp
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Dyslipidemia

Start date: 2011-08-01
Primary completion: 2012-06-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.